2018. Clinical Efficacy or Tildrakizumab in Patients with Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S4. DOI:https://doi.org/10.25251/skin.2.supp.4.